In line with these observations, the killer-cell immunoglobulin-like receptor (KIR) polymorphism, related to diminished cytotoxic activity of NK cells, has been linked to poor response of anti-TNF therapy in a study involving RA patients [66]. The gene discussed is KIR3DL2; the disease is rheumatoid arthritis.